TP53 and female reproductive organ cancer: In contrast to this notion, Guan and colleagues interestingly observed that ARID1A and TP53 mutations are mutually exclusive and that ARID1A acts in concert with p53 to regulate target gene expression including CDKN1A in gynecological cancers [10].